REATA PHARMACEUTICALS INC Quarterly Interest Expense in USD from Q1 2017 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Reata Pharmaceuticals Inc quarterly/annual Interest Expense history and growth rate from Q1 2017 to Q2 2023.
  • Reata Pharmaceuticals Inc Interest Expense for the quarter ending June 30, 2023 was $1.31M.
  • Reata Pharmaceuticals Inc annual Interest Expense for 2022 was $0.000, a 100% decline from 2021.
  • Reata Pharmaceuticals Inc annual Interest Expense for 2021 was $6.56M, a 55.9% decline from 2020.
  • Reata Pharmaceuticals Inc annual Interest Expense for 2020 was $14.9M, a 33% increase from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $1.31M Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q3 2022 $0 -$1.84M -100% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q1 2022 $4.85M $0 -$1.71M -100% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $6.56M $1.24M -$470K -27.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-24
Q3 2021 $7.03M $1.84M +$164K +9.81% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $6.87M $1.77M -$3.87M -68.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $10.7M $1.71M -$4.16M -70.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $14.9M $1.71M -$2.29M -57.2% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-24
Q3 2020 $17.2M $1.67M -$718K -30.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $17.9M $5.64M +$3.23M +134% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $14.7M $5.87M +$3.47M +145% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $11.2M $4M +$1.59M +66.3% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $9.6M $2.39M +$29K +1.23% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $9.57M $2.41M +$1.51M +167% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $8.06M $2.4M +$1.89M +371% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $6.18M $2.4M +$1.91M +384% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $4.27M $2.36M +$1.88M +388% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $2.39M $903K +$435K +92.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $1.96M $509K +$504K +10080% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $1.45M $497K Oct 1, 2017 Dec 31, 2017 10-K 2020-02-19
Q3 2017 $484K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $468K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $5K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.